May 2026: More Wegovy patients have come forward, claiming they experienced non-arteritic anterior ischemic optic neuropathy (NAION) after taking Wegovy based on their doctors instructions
Therefore, we have suggested that doctors [do] not need to hold this medication from patients unless they have underlying eye conditions. Novo Nordisk, the maker of Ozempic, Wegovy and Saxenda, said patient safety is a top priority and that it continuously monitor[s] the safety profile of our medicines in collaboration with the TGA and other regulators worldwide
Retatrutide is not approved by the TGA and is not legally available through standard prescribing
Advances in peptide therapy continue to offer promising avenues for enhanced cognitive function, improved mood, and better overall health
Park A, Conway M
People with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, pancreatitis, or severe gastrointestinal conditions should avoid GLP1 weight-loss drugs unless specifically advised by their physician